Study S003246

A Clinical Study on the Mass Balance of [14C]DA-302168S in Healthy Adult Male Trial Participants in China

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07857265
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 10
Start: 2026-11-20
Primary completion: 2026-12-20
Lead sponsor: Chendu DIAO Pharmaceutical Group CO., LTD.
Conditions: Healthy Adult Subjects
Interventions: DRUG:[14C] DA-302168S
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Total recovery of HDM1002 radioactivity in urine and feces, following oral administration of [14C] DA-302168S [Predose up to Day 8 after administration of [14C]DA-302168S]
Identification of Major Metabolites in Human Plasma, Urine, and Feces [Predose up to Day 8 after administration of [14C]DA-302168S]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.